XBiotech Commences Tender Offer to Purchase up to $80,000,000 Worth of Its Shares
AUSTIN, Texas, May 17, 2023 (GLOBE NEWSWIRE) — Xbiotech Inc. (NASDAQ: XBIT) (“Xbiotech”) announced today…
AUSTIN, Texas, May 17, 2023 (GLOBE NEWSWIRE) — Xbiotech Inc. (NASDAQ: XBIT) (“Xbiotech”) announced today…
The conference will stream live on Monday, June 12, at 10:00 AM EST Tel Aviv,…
The conference will stream live on Monday, June 12, at 10:00 AM EST Tel Aviv,…
– Pure-Vu Gastro achieves high usability scores in supporting upper endoscopy procedures with first time…
– Pure-Vu Gastro achieves high usability scores in supporting upper endoscopy procedures with first time…
SANTA CLARA, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
SANTA CLARA, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
MADRID, Spain and BOSTON, May 17, 2023 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code:…
MADRID, Spain and BOSTON, May 17, 2023 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code:…
Media Release Immuno-oncology combination of eftilagimod alpha (efti) and the leading anti-PD-1 therapy generates meaningful…
Media Release Immuno-oncology combination of eftilagimod alpha (efti) and the leading anti-PD-1 therapy generates meaningful…
Refinanced Loan Extends Maturity to December 2024 SEATTLE and VANCOUVER, British Columbia, May 17, 2023…
Refinanced Loan Extends Maturity to December 2024 SEATTLE and VANCOUVER, British Columbia, May 17, 2023…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
Preclinical results showcase the potential for the strong synergistic combination of chemotherapy and gamma-delta T…
Preclinical results showcase the potential for the strong synergistic combination of chemotherapy and gamma-delta T…
User Fee Goal Date: October 17, 2023 WALTHAM, Mass., May 17, 2023 (GLOBE NEWSWIRE) —…
User Fee Goal Date: October 17, 2023 WALTHAM, Mass., May 17, 2023 (GLOBE NEWSWIRE) —…
Recent upgrades lead to testing results that show customers have the best experience on the…